{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-003334","form_type":"8-K","ticker":"DLB","cik":"0001308547","company_name":"Dolby Laboratories, Inc.","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.149905+00:00","generated_at":"2026-06-25T23:25:52.691663+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Dolby Q2 revenue $334.4M (+4.6% YoY); GAAP EPS $0.36 vs $0.73; declares $0.25 dividend","bullets":["Revenue $334.4M, up 4.6% YoY from $319.6M.","GAAP net income $36.7M ($0.36 diluted EPS), down from $76.2M ($0.73) YoY.","Non-GAAP net income $94.0M ($0.92 diluted EPS), flat vs $94.8M ($0.91) YoY.","Cash from operations $63.0M, compared to $83.5M last year.","Dividend declared $0.25 per share, payable May 25, 2022 to record holders May 17."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-003334","json":"https://secwatch.observer/filing/0001171843-22-003334.json","markdown":"https://secwatch.observer/filing/0001171843-22-003334.md","text":"https://secwatch.observer/filing/0001171843-22-003334.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1308547/000117184322003334/0001171843-22-003334-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1308547/000117184322003334/f8k_050522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T23:25:52.691663+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}